Introduction
============

Age-related maculopathy (ARM) is a common progressive disease that afflicts the elderly population worldwide. ARM has been divided into two stages, early and late \[[@r1]\]. Early stage ARM is characterized by drusen, the deposit of extracellular material between the retinal pigment epithelium and Bruch's membrane, and hyperpigmentation or hypopigmentation of the retinal pigment epithelium (RPE). Late stage age-related maculopathy, also called age-related macular degeneration (AMD), is one of the most common causes of irreversible vision loss in developed countries \[[@r2]\]. AMD is further subdivided into dry and wet forms, which are characterized by geographic atrophy of the RPE and choroidal neovascularization, respectively.

By far, age is the most significant risk factor for ARM \[[@r3]\]. Cigarette smoking \[[@r4]\] and alcohol consumption \[[@r5]-[@r7]\] are two environmental risk factors identified by epidemiological studies. In the past decade, advances in genetic techniques have shown the contribution of genetic predisposition to the etiology of ARM. Genome-wide association studies have successfully identified susceptibility genes and loci for AMD \[[@r8]\]. The complement factor H gene (*CFH*) and 10q26 containing age-related maculopathy susceptibility protein 2 (*ARMS2*, also called *LOC387715*)/HtrA serine peptidase 1 (*HTRA1*) are two major loci associated with AMD identified by genome-wide association studies \[[@r9]-[@r13]\]. The associations have further been confirmed by numerous replication studies \[[@r8]\]. However, most of these studies focus on late stage ARM. The genetic susceptibility of early ARM remains less reported.

In the current study, we investigated the association of *ARMS2/HTRA1* and *CFH* polymorphisms, and environmental exposure including cigarette smoking and alcoholic consumption with prevalence of early ARM in a Chinese cohort. The possible association between the genetic factors and the course or severity of early ARM was also explored.

Methods
=======

Patient recruitment and clinical examinations
---------------------------------------------

This study was approved by the Ethics Committee of Joint Shantou International Eye Center and was conducted in accordance with the Declaration of Helsinki. Written consent was obtained from each participating subject after the nature of the study was explained.

The ARM patients included 39 male and 119 female with age between 50 and 80 years, and controls included 51 male and 106 female with age between 50 and 86 years ([Table 1](#t1){ref-type="table"}). The 315 study subjects were unrelated and included 158 patients with early ARM and 157 controls recruited at a satellite clinic at Nan'ao Island in Shantou, China. All participants underwent comprehensive ophthalmic examinations including best-corrected visual acuity, non-contact tonometry, slit-lamp biomicroscopy of anterior segment, and retina with mydriasis. Stereoscopic color fundus photographs were taken with a Topcon TRC-50EX retina camera (Topcon, Tokyo, Japan). ARM grading of the fundus photos followed the criteria of the Age-Related Eye Disease Study (AREDS) \[[@r14]\] by two independent masked trained graders (H.C. and M.Q.), and kappa statistics were calculated. Inconsistencies between the two graders were resolved by discussion. Subjects with maximal AREDS grades between 1 and 3 were diagnosed with early ARM. The controls had no drusen or pigment abnormality in either eye, and were aged more than 50 years old without family history of AMD. The patients with early ARM and the controls had no other eye diseases except mild senile cataract or refractive error between −6 and +6 diopter. Active cigarette smoking and alcohol consumption status in all participants was collected using a questionnaire. Active smoking was defined as smoking at least five cigarettes per day in the past one or more years \[[@r15]\]. Alcohol consumption history was defined as at least 12 alcoholic drinks in a year in a lifetime \[[@r7]\]. Peripheral blood was collected from all participants. Genomic DNA was extracted with the Qiamp Blood Kit (Qiagen, Hilden, Germany).

###### Demographic and clinical features of the study subjects

  Group     **N**   **Male/ Female**   **Age at diagnosis (year)**   **Cigarette**   **Alcoholic**   **Unilateral/**   **AREDS Grade**            
  --------- ------- ------------------ ----------------------------- --------------- --------------- ----------------- ----------------- -------- ----------
  Control   157     51/106             50--86                        60              61.7±9.2        40/114            37/120            \-       \-
  ARM       158     39/119             50--80                        60              61.6±8.2        31/123            24/133            47/111   73/72/13

ARM: age-related maculopathy; AREDS: Age Related Eye Diseases Study; SD: standard deviation

Single nucleotide polymorphism genotyping
-----------------------------------------

A total of ten single nucleotide polymorphisms (SNPs) previously reported to be associated with AMD \[[@r16]-[@r18]\], including [rs2736911](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2736911), [rs10490924](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10490924), [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638), and [rs2672598](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2672598) in *ARMS2/HTRA1* locus and [rs3753394](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3753394), [rs800292](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=800292), [rs1061170](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1061170), [rs2274700](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2274700), [rs3753396](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3753396), and [rs1065489](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1065489) in *CFH*, were genotyped by using the TaqMan SNP Genotyping assay (Applied Biosystems, Inc. \[ABI\], Foster City, CA) following the protocol suggested by the manufacturer. The quality control of the TaqMan assay reagents was performed by ABI before purchase. A subset of samples was selected to repeat the same TaqMan assays and further validated by using Sanger sequencing, to ensure high-quality genotyping.

Statistical analysis
--------------------

A Hardy--Weinberg test of each SNP and linkage disequilibrium analysis was conducted by using [Haploview](http://www.broadinstitute.org/haploview) version 4.2 \[[@r19]\]. Haplotype block was defined using criteria proposed by Gabriel et al. \[[@r20]\]. Logistic regression controlled for age and sex implemented by the R statistical language version 2.15.1 was used to analyze the association of genetic polymorphisms and environmental exposure \[[@r21]-[@r23]\]. P values and odds ratios (ORs) were calculated using the additive model as previously described \[[@r23],[@r24]\]. For p values less than 0.05, 10,000 permutations were used to correct multiple comparisons. A post-hoc power calculation was performed using [GPower3](http://www.psycho.uni-duesseldorf.de/abteilungen/aap/gpower3/) software.

Results
=======

Demographic and clinical characteristics of study subjects
----------------------------------------------------------

A total of 315 unrelated study subjects including 158 patients with early ARM and 157 controls were recruited. The demographic characteristics are shown in [Table 1](#t1){ref-type="table"}. There was no statistically significant difference in age and gender between the patients and the controls (all p\>0.05, chi-square test and independent Student *t* test). After adjustments for sex and age, neither cigarette smoking nor alcohol consumption showed significant effects on disease onset of early ARM (OR=0.65, p=0.194 and OR=0.95, p=0.916, respectively). Among the 158 patients with early ARM, 47 had unilateral involvement and 111 bilateral. There were 73, 72, and 13 cases of AREDS grades 1, 2, and 3, respectively. The kappa of inter-grader agreement was 0.765.

Hardy--Weinberg equilibrium and linkage equilibrium
---------------------------------------------------

None of the ten SNPs in the current study showed deviation from Hardy--Weinberg equilibrium in the controls (p\>0.05). Linkage disequilibrium analysis showed that the SNPs [rs10490924](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10490924), [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638), and [rs2672598](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2672598) in *ARMS2/HTRA1* form a haplotype block in a 6 kb genomic region (D′\>0.96, [Figure 1A](#f1){ref-type="fig"}). The SNPs [rs2274700](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2274700), [rs3753396](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3753396), and [rs1065489](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1065489) in *CFH* form a long haplotype block in a 26 kb genomic region ([Figure 1B](#f1){ref-type="fig"}).

![Linkage disequilibrium of age-related maculopathy susceptibility protein 2/HtrA serine peptidase 1 and complement factor H single nucleotide polymorphisms. **A**: The single nucleotide polymorphisms (SNPs) rs[10490924](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10490924), [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638), and [rs2672598](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2672598) in age-related maculopathy susceptibility protein 2/HtrA serine peptidase 1 (*ARMS2/HTRA1*) form a haplotype block in a 6 kb genomic region. (**B**) The SNPs [rs10490924](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10490924), [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638), and [rs2672598](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2672598) in complement factor H (*CFH*) form a long haplotype block in a 26 kb genomic region according to the criteria of the confidence intervals, an algorithm proposed by Gabriel et al. \[[@r20]\]. The solid line with an arrow indicates the transcription direction.](mv-v19-944-f1){#f1}

Association with disease onset of early age-related maculopathy
---------------------------------------------------------------

The SNPs in *ARMS2/HTRA1* and *CFH* showed no significant association with early ARM (all p values\>0.05, [Table 2](#t2){ref-type="table"} and [Table 3](#t3){ref-type="table"}). The ORs of these SNPs ranged from 0.88 and 1.17 and were close to 1.

###### Association of *ARMS2/HTRA1* SNPs with early ARM

  SNP                                                                              Genotype   Frequency   Association                                
  -------------------------------------------------------------------------------- ---------- ----------- ------------- ----- ------ --------------- -------
  [rs2736911](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2736911)     CC         125         79.6          131   82.9   0.90            0.773
                                                                                   CT         30          19.1          23    14.6   (0.53 - 1.5)    
                                                                                   TT         2           1.3           4     2.5                    
                                                                                   C          280         89.2          285   90.2                   
                                                                                   T          34          10.8          31    9.8                    
                                                                                                                                                     
  [rs10490924](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10490924)   GG         60          38.2          60    38     1.12            0.553
                                                                                   GT         78          49.7          71    44.9   (0.81 - 1.54)   
                                                                                   TT         19          12.1          27    17.1                   
                                                                                   G          198         63.1          191   60.4                   
                                                                                   T          116         36.9          125   39.6                   
                                                                                                                                                     
  [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638)   GG         59          37.6          56    35.4   1.14            0.453
                                                                                   AG         77          49            74    46.8   (0.83 - 1.58)   
                                                                                   AA         21          13.4          28    17.7                   
                                                                                   G          195         62.1          186   58.9                   
                                                                                   A          119         37.9          130   41.1                   
                                                                                                                                                     
  [rs2672598](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2672598)     TT         72          45.9          81    51.3   0.88            0.511
                                                                                   CT         69          43.9          61    38.6   (0.63 - 1.23)   
                                                                                   CC         16          10.2          16    10.1                   
                                                                                   T          213         67.8          223   70.6                   
                                                                                   C          101         32.2          93    29.4                   

The ORs of the minor alleles were calculated using the additive model controlling both sex and age. SNP: single nucleotide polymorphism; ARM: age-related maculopathy; OR: odds ratio; CI: confidence interval.

###### Association of *Complement factor H* SNPs with early ARM

  SNP                                                                            Genotype   Frequency   Association                              
  ------------------------------------------------------------------------------ ---------- ----------- ------------- ----- ------ ------------- -------
  [rs3753394](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3753394)   TT         49          31.2          51    32.3   1.04          0.868
                                                                                 TC         74          47.1          68    43     0.76 - 1.42   
                                                                                 CC         34          21.7          39    24.7                 
                                                                                 T          172         54.8          170   53.8                 
                                                                                 C          142         45.2          146   46.2                 
                                                                                                                                                 
  [rs800292](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=800292)     GG         51          32.5          55    34.8   1.08          0.680
                                                                                 GA         79          50.3          66    41.8   0.79 - 1.48   
                                                                                 AA         27          17.2          37    23.4                 
                                                                                 G          181         57.6          176   55.7                 
                                                                                 A          133         42.4          140   44.3                 
                                                                                                                                                 
  [rs1061170](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1061170)   CC         144         91.7          146   92.4   0.91          0.987
                                                                                 CT         13          8.3           12    7.6    0.4 - 2.07    
                                                                                 TT         0           0             0     0                    
                                                                                 C          301         95.9          304   96.2                 
                                                                                 T          13          4.1           12    3.8                  
                                                                                                                                                 
  [rs2274700](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2274700)   CC         49          31.2          48    30.4   1.17          0.372
                                                                                 CT         84          53.5          75    47.5   0.85 - 1.6    
                                                                                 TT         24          15.3          35    22.2                 
                                                                                 C          182         58            171   54.1                 
                                                                                 T          132         42            145   45.9                 
                                                                                                                                                 
  [rs3753396](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3753394)   GG         39          24.8          42    26.6   1.09          0.632
                                                                                 AG         83          52.9          71    44.9   0.8 - 1.49    
                                                                                 AA         35          22.3          45    28.5                 
                                                                                 G          161         51.3          155   49.1                 
                                                                                 A          153         48.7          161   50.9                 
                                                                                                                                                 
  [rs1065489](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1065489)   TT         39          24.8          41    25.9   1.08          0.690
                                                                                 GT         82          52.2          73    46.2   0.79 - 1.48   
                                                                                 GG         36          22.9          44    27.8                 
                                                                                 T          160         51            155   49.1                 
                                                                                 G          154         49            161   50.9                 

The ORs of the minor alleles were calculated using the additive model controlling both sex and age. SNP: single nucleotide polymorphism; ARM: age-related maculopathy; OR: odds ratio; CI: confidence interval.

Association with unilateral and bilateral early age-related maculopathy
-----------------------------------------------------------------------

The association of SNPs in *ARMS2/HTRA1* and *CFH* were further tested in patients with unilateral and bilateral ARM. No significance was observed in the *ARMS2/HTRA1* and *CFH* SNPs in the patients with unilateral ARM (p\>0.622 and p\>0.249, respectively, [Table 4](#t4){ref-type="table"} and [Table 5](#t5){ref-type="table"}). Likewise, none of the *ARMS2/HTRA1* and *CFH* SNPs showed significance in the patients with bilateral ARM (p\>0.709 and p\>0.348, respectively, [Table 4](#t4){ref-type="table"} and [Table 5](#t5){ref-type="table"})

###### Association of *ARMS2/HTRA1* SNPs with unilateral and bilateral early ARM

  Genotype frequency                                                               Genotype frequency   Association                                                                   
  -------------------------------------------------------------------------------- -------------------- ------------- ---- ------ ---- ------ --------------- ------- --------------- -------
  [rs2736911](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2736911)                                                                                                        
  CC                                                                               125                  79.6          39   83     92   82.9   0.78            0.538   0.94            0.809
  CT                                                                               30                   19.1          8    17     15   13.5   (0.32 - 1.67)           (0.54 - 1.59)   
  TT                                                                               2                    1.3           0    0      4    3.6                                            
                                                                                                                                                                                      
  [rs10490924](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10490924)                                                                                                      
  GG                                                                               60                   38.2          21   44.7   39   35.1   0.98            0.931   1.22            0.277
  GT                                                                               78                   49.7          18   38.3   53   47.7   (0.6 - 1.58)            (0.85 - 1.76)   
  TT                                                                               19                   12.1          8    17     19   17.1                                           
                                                                                                                                                                                      
  [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638)                                                                                                      
  GG                                                                               59                   37.6          20   42.6   36   32.4   1.03            0.898   1.24            0.249
  AG                                                                               77                   49            18   38.3   56   50.5   (0.64 - 1.65)           (0.86 - 1.78)   
  AA                                                                               21                   13.4          9    19.1   19   17.1                                           
                                                                                                                                                                                      
  [rs2672598](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2672598)                                                                                                        
  TT                                                                               72                   45.9          23   48.9   58   52.3   0.88            0.622   0.86            0.429
  CT                                                                               69                   43.9          20   42.6   41   36.9   (0.52 - 1.45)           (0.59 - 1.24)   
  CC                                                                               16                   10.2          4    8.5    12   10.8                                           

The ORs of the minor alleles were calculated using the additive model controlling both sex and age. SNP: single nucleotide polymorphism; ARM: age-related maculopathy; OR: odds ratio; CI: confidence interval.

###### Association of *Complement facor H* SNPs with unilateral and bilateral early ARM

  Genotype frequency                                                                   Genotype frequency   Association                                                               
  ------------------------------------------------------------------------------ ----- -------------------- ------------- ------ ----- ------ --------------- ------- --------------- -------
  [rs3753394](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3753394)                                                                                                        
  TT                                                                             49    31.2                 17            36.2   34    30.6   0.95            0.835   1.07            0.712
  TC                                                                             74    47.1                 19            40.4   49    44.1   (0.6 - 1.5)             (0.76 - 1.49)   
  CC                                                                             34    21.7                 11            23.4   28    25.2                                           
                                                                                                                                                                                      
  [rs800292](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=800292)                                                                                                          
  GG                                                                             51    32.5                 17            36.2   38    34.2   1.01            0.966   1.07            0.684
  GA                                                                             79    50.3                 20            42.6   46    41.4   (0.63 - 1.61)           (0.76 - 1.51)   
  AA                                                                             27    17.2                 10            21.3   27    24.3                                           
                                                                                                                                                                                      
  [rs1061170](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1061170)                                                                                                        
  CC                                                                             144   91.7                 44            93.6   102   91.9   0.78            0.709   0.99            0.989
  CT                                                                             13    8.3                  3             6.4    9     8.1    (0.17 - 2.57)           (0.39 - 2.41)   
  TT                                                                             0     0                    0             0      0     0                                              
                                                                                                                                                                                      
  [rs2274700](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2274700)                                                                                                        
  CC                                                                             49    31.2                 16            34     32    28.8   1.09            0.721   1.19            0.348
  CT                                                                             84    53.5                 21            44.7   54    48.6   (0.67 - 1.78)           (0.83 - 1.7)    
  TT                                                                             24    15.3                 10            21.3   25    22.5                                           
                                                                                                                                                                                      
  [rs3753396](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3753396)                                                                                                        
  GG                                                                             39    24.8                 14            29.8   28    25.2   1.07            0.777   1.09            0.632
  AG                                                                             83    52.9                 19            40.4   52    46.8   (0.67 - 1.71)           (0.77 - 1.55)   
  AA                                                                             35    22.3                 14            29.8   31    27.9                                           
                                                                                                                                                                                      
  [rs1065489](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1065489)                                                                                                        
  TT                                                                             39    24.8                 14            29.8   27    24.3   1.06            0.817   1.09            0.644
  GT                                                                             82    52.2                 19            40.4   54    48.6   (0.66 - 1.68)           (0.77 - 1.54)   
  GG                                                                             36    22.9                 14            29.8   30    27                                             

The ORs of the minor alleles were calculated using the additive model controlling both sex and age. SNP: single nucleotide polymorphism; ARM: age-related maculopathy; OR: odds ratio; CI: confidence interval.

Association with Age-Related Eye Disease Study grading of early age-related maculopathy
---------------------------------------------------------------------------------------

No significant association of the *ARMS2*/*HTRA1* and *CFH* SNPs with any grade of ARM was found in the current cohort (all p\>0.125, [Table 6](#t6){ref-type="table"} and [Table 7](#t7){ref-type="table"}).

###### Association of *ARMS2/HTRA1* SNPs with AREDS grading of early ARM

  SNP                                                                              Genotype frequency   Association                                                                                                              
  -------------------------------------------------------------------------------- -------------------- ------------- ------ ---- ------ ---- ------ ---- ------ --------------- ------- --------------- ------- --------------- -------
  [rs2736911](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2736911)     CC                   125           79.6   60   82.2   60   83.3   11   84.6   0.94            0.858   0.89            0.727   0.70            0.641
                                                                                   CT                   30            19.1   11   15.1   10   13.9   2    15.4   (0.49 - 1.74)           (0.46 - 1.66)           (0.11 - 2.51    
                                                                                   TT                   2             1.3    2    2.7    2    2.8    0    0                                                                      
                                                                                                                                                                                                                                 
  [rs10490924](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10490924)   GG                   60            38.2   29   39.7   26   36.1   5    38.5   1.1             0.645   1.17            0.466   1.11            0.819
                                                                                   GT                   78            49.7   31   42.5   34   47.2   6    46.2   (0.73 - 1.67)           (0.77 - 1.77)           (0.46 - 2.6     
                                                                                   TT                   19            12.1   13   17.8   12   16.7   2    15.4                                                                   
                                                                                                                                                                                                                                 
  [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638)   GG                   59            37.6   27   37     24   33.3   5    38.5   1.14            0.539   1.19            0.414   1.07            0.877
                                                                                   AG                   77            49     32   43.8   36   50     6    46.2   (0.75 - 1.71)           (0.78 - 1.8)            (0.44 - 2.49)   
                                                                                   AA                   21            13.4   14   19.2   12   16.7   2    15.4                                                                   
                                                                                                                                                                                                                                 
  [rs2672598](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2672598)     TT                   72            45.9   37   50.7   39   54.2   5    38.5   0.93            0.751   0.75            0.205   1.27            0.565
                                                                                   CT                   69            43.9   27   37     28   38.9   6    46.2   (0.61 - 1.42)           (0.48 - 1.16)           (0.54 - 2.89)   
                                                                                   CC                   16            10.2   9    12.3   5    6.9    2    15.4                                                                   

The ORs of the minor alleles were calculated using the additive model controlling both sex and age. SNP: single nucleotide polymorphism; ARM: age-related maculopathy; AREDS: Age related eye diseases study; OR: odds ratio; CI: confidence interval.

###### Association of *Complement factor H* SNPs with AREDS grading of early ARM

  SNP                                                                            Genotype Frequency   Association                                                                                                              
  ------------------------------------------------------------------------------ -------------------- ------------- ------ ---- ------ ---- ------ ---- ------ --------------- ------- --------------- ------- --------------- -------
  [rs3753394](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3753394)   TT                   49            31.2   20   27.4   26   36.1   5    38.5   1.22            0.312   0.85            0.415   1.07            0.863
                                                                                 TC                   74            47.1   31   42.5   33   45.8   4    30.8   (0.83 - 1.8)            (0.57 - 1.25)           (0.48 - 2.35)   
                                                                                 CC                   34            21.7   22   30.1   13   18.1   4    30.8                                                                   
                                                                                                                                                                                                                               
  [rs800292](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=800292)     GG                   51            32.5   21   28.8   28   38.9   6    46.2   1.22            0.328   0.91            0.641   1.02            0.963
                                                                                 GA                   79            50.3   33   45.2   30   41.7   3    23.1   (0.82 - 1.83)           (0.61 - 1.35)           (0.44 - 2.29)   
                                                                                 AA                   27            17.2   19   26     14   19.4   4    30.8                                                                   
                                                                                                                                                                                                                               
  [rs1061170](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1061170)   CC                   144           91.7   65   89     69   95.8   12   92.3   1.43            0.453   0.5             0.29    0.96            0.969
                                                                                 CT                   13            8.3    8    11     3    4.2    1    7.7    (0.54 - 3.62)           (0.11 - 1.61)           (0.05 - 5.58)   
                                                                                 TT                   0             0      0    0      0    0      0    0                                                                      
                                                                                                                                                                                                                               
  [rs2274700](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1061170)   CC                   49            31.2   18   24.7   25   34.7   5    38.5   1.39            0.125   1.01            0.958   0.9             0.807
                                                                                 CT                   84            53.5   36   49.3   33   45.8   6    46.2   (0.92 - 2.11)           (0.67 - 1.53)           (0.36 - 2.12)   
                                                                                 TT                   24            15.3   19   26     14   19.4   2    15.4                                                                   
                                                                                                                                                                                                                               
  [rs3753396](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3753396)   GG                   39            24.8   15   20.5   22   30.6   5    38.5   1.37            0.125   0.89            0.556   0.92            0.84
                                                                                 AG                   83            52.9   33   45.2   34   47.2   4    30.8   (0.92 - 2.08)           (0.59 - 1.32)           (0.4 - 2.09)    
                                                                                 AA                   35            22.3   25   34.2   16   22.2   4    30.8                                                                   
                                                                                                                                                                                                                               
  [rs1065489](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1065489)   TT                   39            24.8   15   20.5   21   29.2   5    38.5   1.37            0.129   0.9             0.624   0.76            0.524
                                                                                 GT                   82            52.2   33   45.2   35   48.6   5    38.5   (0.92 - 2.06)           (0.6 - 1.35)            (0.32 - 1.74)   
                                                                                 GG                   36            22.9   25   34.2   16   22.2   3    23.1                                                                   

The ORs of the minor alleles were calculated using the additive model controlling both sex and age. SNP: single nucleotide polymorphism; ARM: age-related maculopathy; AREDS: Age related eye diseases study; OR: odds ratio; CI: confidence interval.

Discussion
==========

Our results showed no association between ten SNPs in the two major AMD-associated genetic loci, *CFH* and *ARMS2*/*HTRA1,* with either disease onset or course of early ARM in a Han Chinese cohort. The association of *CFH* SNP [rs1061170](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1061170) (Y402H) with late stage AMD was first discovered with a genome-wide association study. Later, it was reported that the Y402H variation was also associated with soft drusen in Caucasians \[[@r25]-[@r27]\]. However, the association of Y402H with hard drusen remains controversial. Positive \[[@r25]\] and negative \[[@r27],[@r28]\] results have been reported in investigating the association of Y402H and hard drusen in Caucasians. There was ethnic variation in the minor allele frequency of Y402H and its association with AMD. In a Latino population, Y402H was reported to be associated only with bilateral early AMD but not unilateral early AMD \[[@r29]\]. The minor allele frequency of Y402H is low in East Asians and contributes to a small portion of AMD. In a multiethnic study in the United States, Y402H was associated with early AMD in Caucasians and Hispanics but not Chinese or Black groups \[[@r30]\]. In Chinese, the results are controversial. In a report of Taiwanese Chinese, Y402H was associated with early AMD \[[@r31]\]. In the Beijing Eye Study, Y402H was associated with bilateral but not unilateral soft drusen \[[@r32]\]. In another report, no SNP in *CFH* was associated with drusen \[[@r33]\]. Similar results were observed at the genotype level. The absence of a homozygous minor genotype of [rs1061170](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1061170) and the high frequency of the homozygous major genotype in controls were similar to those reported in other East Asian populations, including Korean, Japanese, and other Chinese cohorts. In early ARM, the frequency of the homozygous minor genotype of [rs1061170](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1061170) was reported to be 6% in the Taiwan study \[[@r31]\]; however, the genotype was shown to be rare in rare (1.4%) in the Beijing Eye study \[[@r32]\]. Our study also found no association of Y402H in *CFH* with early AMD, either unilateral or bilateral. It was reported that in Chinese, the significant AMD-associated SNP was not Y402H but other SNPs, such as [rs3753394](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3753394), [rs800292](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=800292), and [rs2274700](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2274700) \[[@r34]\]. In our study, we also excluded the association of these SNPs with early ARM.

The 10q26 locus is another major locus associated with AMD. Two genes in this locus were associated with AMD, *ARMS2* \[[@r35]\] and *HTRA1* \[[@r12],[@r13]\]. The [rs10490924](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10490924) at *ARMS2* and [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638) at *HTRA1* were in high linkage disequilibrium. Currently, there is still debate over which gene if not both contributes to AMD risk. It was reported that in a population in Utah the [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638) at *HTRA1* was associated with soft drusen \[[@r36]\]. In the AREDS cohort, [rs10490924](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10490924) at *ARMS2* was associated with large drusen only but not intermediate drusen \[[@r37]\]. However, in a Russian and Greek population, *ARMS2* was associated only with late AMD but not early AMD \[[@r38],[@r39]\]. In a Chinese population, [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638) at *HTRA1* was not associated with drusen \[[@r40]\]. In a Danish population, the presence of 20 or more small hard drusen was not observed with [rs10490924](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10490924) at *ARMS2* or [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638) at *HTRA1* \[[@r28]\]. In this study of a Chinese cohort, we found that [rs10490924](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10490924), [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638), [rs2672598](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2672598), and [rs2736911](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2736911) were not associated with early AMD.

The ten SNPs in *CFH* and *ARMS2*/*HTRA1* have been previously reported to be significantly associated with AMD \[[@r9]-[@r13],[@r17]\]. In our cohort of early ARM, no association of the ten SNPs in *ARMS2*/*HTRA1* and *CFH* was detected. The ORs of association with ARM was close to 1, probably suggesting that the effect sizes of *CFH* and *ARMS2/HTRA1* SNPs in early ARM could be much lower compared to those previously reported for AMD in Chinese \[[@r16]-[@r18],[@r31]\]. Furthermore, our findings indicated that *ARMS2/HTRA1* and *CFH* SNPs were unlikely to be involved in disease severity or course. The ORs of the SNPs rs10490924 and [rs11200638](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638) increased in bilateral early ARM compared to unilateral ARM. However, the association did not reach statistical significance, and the effect sizes were similarly much smaller compared to those in AMD. The ORs did not show a consistent trend with the grade or increased early ARM, which thus further suggested the lack of involvement of the ARMS2*/HTRA1* and *CFH* SNPs in disease severity. Lower post-hoc power was observed in the unilateral early ARM test, probably due to the small sample size. Although [rs2736911](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2736911) in *ARMS2* and rs1065489 in *CFH* had relatively lower power (56% and 66%, respectively), most of the SNPs in the current study showed high post-hoc power (≥73%) in the total early ARM test and the bilateral early ARM test (Appendix 1 and Appendix 2).

Ethnic variation in prevalence has been revealed by the epidemiology of ARM. The Beijing Eye Study reported the prevalence of early ARM in Chinese individuals aged 40 or more years reported as 1.4% \[[@r41]\]. Similarly, early ARM has a lower prevalence in other East Asians such as Japanese compared to Caucasians of European descent \[[@r42]\]. Such variation is in line with the difference in genetics of early ARM found in the current study.

In addition to genetic factors, environmental exposure such as cigarette smoking has been shown to be involved in the development of AMD \[[@r17],[@r43]-[@r45]\]. However, active cigarette smoking did not show significant effects on disease onset of early ARM in the current study (with an OR close to 1). Alcohol consumption showed an OR equal to 0.65, with the p value equal to 0.194. Further investigation is needed to study the effects of alcohol consumption in early ARM.

In conclusion, our results showed no association between the two major AMD associated loci and early ARM in terms of disease onset or course. In contrast to the strong genetic contribution to AMD, these findings suggest a much smaller effect of the two major AMD-associated loci on the etiology of early ARM, and thus implicate differential pathophysiological mechanisms between early ARM and AMD.
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